Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Allegra Orthopaedics (AMT) has started distributing Australian made and designed face shields to front line workers
  • The company has already received 105,000 face shield orders and is in discussions with major hospital groups who are interested in the product
  • Healthcare workers rely on equipment and uniforms to protect themselves against COVID-19
  • Allegra says it is monitoring its expenditure during these challenging times
  • The face shields are expected to give the company some extra cash in the hand
  • Allegra is down 23.1 per cent on the market today, trading for 15¢ apiece

Allegra Orthopaedics (AMT) has started distributing Australian made and designed face shields to front line workers.

The company has already received 105,000 face shield orders and is in discussions with major hospital groups who are interested in the product.

These face shields have been approved by the Therapeutic Goods Administration (TGA).

Allegra says it is monitoring its expenditure during these challenging times. The face shields are expected to give the company some extra cash in the hand as the Federal Government suspended all elective surgeries in public and private hospitals.

CEO Jenny Swain is proud to supply Australian designed and manufactured face shields to the front line carers.

“The current demand for PPE Illustrates the need for companies to be ready to diversify during this global uncertainty surrounding COVID-19,” she said.

“I am pleased to say that Allegra has been proactive in making this happen and more importantly, we are supporting Australian manufacturing,” she added.

Allegra is down 23.1 per cent on the market today, trading for 15¢ apiece at 1:54 pm AEST.

AMT by the numbers
More From The Market Herald
The Market Herald Video

" Cynata Therapeutics (ASX:CYP) to conclude MEND trial following strategic review

Cynata Therapeutics (ASX:CYP) has completed a strategic review of its clinical development pipeline to maximise commercial…
The Market Herald Video

" AVITA Medical (ASX:AVH) reports positive results from soft tissue trial

AVITA Medical (ASX:AVH) reports positive top line results for its RECELL trial in patients with soft-tissue…
Paradigm Biopharmaceuticals (ASX:PAR) - CEO, Marco Polizzi

" Paradigm Biopharmaceuticals (ASX:PAR) enters trading halt amid cap raise

Paradigm Biopharmaceuticals (ASX:PAR) has entered into a trading halt ahead of a capital raise.
HITIQ (ASX:HIQ) - CEO, Mike Vegar

" HITIQ (ASX:HIQ) secures third Australian innovation patent

HITIQ (ASX:HIQ) has secured a third Australian innovation patent related to its virtual reality (VR) concussion…